TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
IQV

IQVIA Holdings Inc

Healthcare · Diagnostics & Research

267.90$ -0.8% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios IQV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
32.7 31.4 34.3 27.4 31.1 25.9 23.4 22.1 25.4 28.5 20.9 23.7
2.5 2.8 3.1 2.6 2.9 2.3 2.0 1.7 2.1 2.4 1.7 1.9
6.3 7.0 7.3 5.8 6.3 5.9 5.2 4.7 5.3 6.0 4.7 5.3
3.3 3.7 3.9 3.3 3.6 3.1 2.8 2.6 2.9 3.2 2.6 2.7
15.5 16.9 18.0 15.1 16.8 13.8 12.7 12.2 13.3 15.2 12.2 13.2
27.6 28.4 28.7 21.3 22.3 16.8 14.5 13.6 12.4 15.6 11.4 12.5
3.6% 3.5% 3.5% 4.7% 4.5% 6.0% 6.9% 7.4% 8.1% 6.4% 8.8% 8.0%
Margins
34.9% 35.0% 35.0% 33.3% 33.4% 33.1% 33.0% 34.2% 33.8% 26.3% 26.1% 26.2%
12.5% 13.2% 13.4% 13.4% 13.7% 14.5% 14.3% 13.9% 13.7% 14.0% 13.9% 13.6%
7.5% 9.1% 9.0% 9.4% 9.2% 8.9% 8.6% 7.9% 8.1% 8.3% 8.3% 8.1%
8.9% 10.0% 10.8% 12.1% 12.8% 13.7% 14.0% 12.8% 16.6% 15.2% 15.3% 15.4%
Returns
19.2% 22.2% 21.4% 21.2% 20.2% 22.6% 22.3% 21.4% 20.8% 20.9% 22.3% 22.3%
4.3% 5.1% 5.1% 5.4% 5.2% 5.1% 4.9% 4.3% 4.5% 4.5% 4.7% 4.6%
Balance Sheet & Debt
12,407 12,297 12,092 11,713 11,940 12,281 12,590 13,451 13,143 13,744 13,886 14,090
3.9 3.8 3.7 3.5 3.6 3.5 3.6 4.0 3.8 4.0 3.9 4.0
22.3% 22.9% 23.9% 25.4% 25.6% 22.6% 21.9% 20.2% 21.4% 21.7% 21.0% 20.7%
2.3 2.2 2.1 2.0 1.9 2.3 2.4 2.7 2.4 2.4 2.5 2.6
Per Share
6.02 7.37 7.36 7.72 7.63 7.59 7.52 7.14 7.47 7.91 8.16 8.16
80.08 81.30 81.76 82.23 83.14 85.20 87.36 90.65 92.63 94.88 97.95 100.73
31.29 33.16 34.42 36.43 37.82 33.56 33.69 33.36 35.88 37.83 36.64 36.60
7.12 8.14 8.81 9.91 10.65 11.69 12.19 11.61 15.38 14.43 14.99 15.50

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?